FdaApplication

NDA 213976

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date2024-02-09

Products (1)

ProductActive ingredientStrengthDosage form
EOHILIABUDESONIDE2MG/10MLSUSPENSION;ORAL

1 product